G-Strophanthin (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "G-Strophanthin" in German language version.

refsWebsite
Global rank German rank
4th place
7th place
2nd place
3rd place
813th place
69th place
68th place
29th place
low place
979th place
low place
low place
low place
low place
1st place
1st place
743rd place
45th place
low place
4,774th place
low place
2,661st place

derstandard.at (Global: 743rd place; German: 45th place)

dgk.org (Global: low place; German: 4,774th place)

leitlinien.dgk.org

dguv.de (Global: 813th place; German: 69th place)

gestis.dguv.de

doi.org (Global: 2nd place; German: 3rd place)

europa.eu (Global: 68th place; German: 29th place)

chem.echa.europa.eu

medizin-transparent.at (Global: low place; German: 2,661st place)

nih.gov (Global: 4th place; German: 7th place)

ncbi.nlm.nih.gov

  • Van de Werf F et al.: Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2008 Dec;29(23):2909-45. PMID 19004841.
  • W. Schoner, G. Scheiner-Bobis: Endogenous and exogenous cardiac glycosides and their mechanisms of action. In: American Journal of Cardiovascular Drugs. Band 7, Nummer 3, 2007, S. 173–189, PMID 17610345. (Review).
  • S. Baecher, M. Kroiss, M. Fassnacht, M. Vogeser: No endogenous ouabain is detectable in human plasma by ultra-sensitive UPLC-MS/MS. In: Clinica Chimica Acta. Band 431, April 2014, S. 87–92, doi:10.1016/j.cca.2014.01.038. PMID 24508998.
  • L. K. Lewis, T. G. Yandle, P. J. Hilton, B. P. Jensen, E. J. Begg, M. G. Nicholls: Endogenous ouabain is not ouabain. In: Hypertension. Band 64, Nummer 4, Oktober 2014, S. 680–683, doi:10.1161/HYPERTENSIONAHA.114.03919. PMID 25001271.
  • Gao J, Wymore RS, Wang Y, et al.: Isoform-specific stimulation of cardiac Na/K pumps by nanomolar concentrations of glycosides. In: J. Gen. Physiol. 119. Jahrgang, Nr. 4, April 2002, S. 297–312, PMID 11929882, PMC 2238186 (freier Volltext).
  • Balzan S, D'Urso G, Nicolini G, Forini F, Pellegrino M, Montali U: Erythrocyte sodium pump stimulation by ouabain and an endogenous ouabain-like factor. In: Cell Biochem. Funct. 25. Jahrgang, Nr. 3, 2007, S. 297–303, doi:10.1002/cbf.1387, PMID 17191274.
  • Nesher M, Shpolansky U, Viola N, et al.: Ouabain attenuates cardiotoxicity induced by other cardiac steroids. In: Br. J. Pharmacol. 160. Jahrgang, Nr. 2, Mai 2010, S. 346–54, doi:10.1111/j.1476-5381.2010.00701.x, PMID 20423344.
  • Belz GG, Matthews J, Sauer U, Stern H, Schneider B: Pharmacodynamic effects of ouabain following single sublingual and intravenous doses in normal subjects. In: European Journal of Clinical Pharmacology. 26. Jahrgang, Nr. 3, 1984, S. 287–92, PMID 6428911.
  • Sharma B, Majid PA, Meeran MK, Whitaker W, Taylor SH: Clinical, electrocardiographic, and haemodynamic effects of digitalis (ouabain) in angina pectoris. In: British Heart Journal. 34. Jahrgang, Nr. 6, Juni 1972, S. 631–7, PMID 4402698, PMC 458511 (freier Volltext).
  • Fürstenwerth H: Ouabain – the insulin of the heart. In: Int. J. Clin. Pract. 64. Jahrgang, Nr. 12, November 2010, S. 1591–4, doi:10.1111/j.1742-1241.2010.02395.x, PMID 20946265.

chem.nlm.nih.gov

pubchem.ncbi.nlm.nih.gov

reach-clp-biozid-helpdesk.de (Global: low place; German: 979th place)

serva.de (Global: low place; German: low place)

versorgungsleitlinien.de (Global: low place; German: low place)

  • Nationale Versorgungsleitlinie der Bundesärztekammer, Chronische KHK, Version 1.8, April 2008. Online als PDF.

web.archive.org (Global: 1st place; German: 1st place)